Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03340129
Title Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study) (ABC-X)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Melanoma Institute Australia
Indications

mucosal melanoma

melanoma

skin melanoma

acral lentiginous melanoma

Therapies

Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Westmead Hospital Recruiting Sydney New South Wales 2145 Australia Details
Calvary Mater NewcastleHospital Recruiting Waratah New South Wales 2298 Australia Details
Melanoma Institute Australia Recruiting Wollstonecraft New South Wales 2065 Australia Details
Princess Alexandra Hospital Recruiting Woolloongabba Queensland 4102 Australia Details
Royal Adelaide Hospital Not yet recruiting Adelaide South Australia 5000 Australia Details
Peter MacCallum Cancer Centre Recruiting East Melbourne Victoria 3002 Australia Details
Alfred Hospital Not yet recruiting Melbourne Victoria 3004 Australia Details
Oslo Univesity Hospital Radiumhospitalet Not yet recruiting Oslo 0379 Norway Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field